Generic pill could be alternative to oral antivirals in COVID-19
pharmaphorum
OCTOBER 28, 2021
The antidepressant fluvoxamine given as a twice-daily regimen for 10 days to acutely symptomatic patients with COVID-19 who also had at least one risk factor such as diabetes, cardiovascular disease, underlying respiratory conditions such as chronic asthma and obesity.
Let's personalize your content